SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Euller-Ziegler L, Chami H, Tran A, Benzaken S, Lussiez V, Rampal P, et al. Rheumatic manifestations of hepatitis C virus infection [Abstract]. Rheumatol Eur 1995; 24 Suppl 3: B101.
  • 2
    Lee YH, Ji JD, Yeon JE, Byun KS, Lee CH, Song GG. Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis 1998; 57: 72831.
  • 3
    Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N, et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998; 28: 10713.
  • 4
    Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999; 42: 220412.
  • 5
    Rivera J, Garcia-Monforte A, Pineda A, Millan Nunez-Cortes J. Arthritis in patients with chronic hepatitis C virus infection. J Rheumatol 1999; 26: 4204.
  • 6
    Zuckerman E, Keren D, Rozenbaum M, Toubi E, Slobodin G, Tamir A, et al. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha. Clin Exp Rheumatol 2000; 18: 57984.
  • 7
    Rosner I, Rozenbaum M, Toubi E, Kessel A, Naschitz JE, Zuckerman E. The case for hepatitis C arthritis. Semin Arthritis Rheum 2004; 33: 37587.
  • 8
    Olivieri I, Palazzi C, Padula A. Hepatitis C virus and arthritis. Rheum Dis Clin North Am 2003; 29: 11122.
  • 9
    Yamamoto T, Katayama I, Nishioka K. Psoriasis and hepatitis C virus. Acta Derm Venereol 1995; 75: 4823.
  • 10
    Chouela E, Abeldano A, Panetta J, Ducard M, Neglia V, Sookoian S, et al. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol 1996; 35: 7979.
  • 11
    Burrows NP, Norris PG, Alexander G, Wreghitt T. Chronic hepatitis C infection and psoriasis [letter]. Dermatology 1995; 190: 173.
  • 12
    Taglione E, Vatteroni ML, Martini P, Galluzzo E, Lombardini F, Delle Sedie A, et al. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol 1999; 26: 3702.
  • 13
    Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA): an analysis of 220 patients. QJM 1987; 62: 12741.
  • 14
    Bennet RM. Psoriatic arthritis. In: KoopmanWJ, Editor. Arthritis and allied conditions. 14th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 134561.
  • 15
    Palazzi C, Olivieri I, Petricca A, Salvarani C. Rheumatoid arthritis or psoriatic symmetric polyarthritis? A difficult differential diagnosis. Clin Exp Rheumatol 2002; 20: 34.
  • 16
    Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 5578.
  • 17
    Fadda P, la Civita L, Zignego AL, Ferri C. Epatite C e artrite: studio clinico-sierologico dell'artrite in pazienti con e senza sindrome crioglobulinemica. Reumatismo 2002; 54: 31623. In Italian.
  • 18
    Medina Rodriguez F. Rheumatic manifestations of human immunodeficiency virus infection. Rheum Dis Clin North Am 2003; 29: 14561.
  • 19
    Vasey FB, Deitz C, Fenske NA, Germain BF, Espinoza LR. Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 1982; 9: 71922.
  • 20
    Lapadula G, Iannone F, Covelli M, Numo R, Pipitone V. Anti-enterobacteria antibodies in psoriatic arthritis. Clin Exp Rheumatol 1992; 10: 4616.
  • 21
    Kessel A, Rosner I, Zuckerman E, Golan TD, Toubi E. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. J Rheumatol 2000; 27: 6102.
  • 22
    Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004; 6: R13741.
  • 23
    Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 97983.
  • 24
    Zignego AL, Ferri C, Monti M, LaCivita L, Giannini C, Careccia G, et al. Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications. Clin Exp Rheumatol 1995; 13 Suppl 13: S337.
  • 25
    Ferri C, la Civita L, Longombardo G, Greco F, Bombardieri S. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 1993; 23: 399-405.
  • 26
    Sagnelli E, Gaeta GB, Felaco FM, Stroffolini T, Conti S, Glielmo A, et al. Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: a multicentre case-control study. Infection 1997; 25: 3469.
  • 27
    Osella AR, Sonzogni L, Cavallini A, Foti L, Guerra V, di Leo A, et al. Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population-based study. J Clin Microbiol 1999; 37: 23712.
  • 28
    Maggi G, Armitano S, Brambilla L, Brenna M, Cairo M, Galvani G, et al. Hepatitis C infection in an Italian population not selected for risk factors. Liver 1999; 19: 42731.
  • 29
    Raffaele A, Valenti M, Iovenitti M, Matani A, Bruno ML, Altobelli E, et al. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol 2001; 17: 416.
  • 30
    Campello C, Poli A, Dal MG, Besozzi-Valentini F. Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Infection 2002; 30: 712.
  • 31
    Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Rio J, Rodriguez Perez A, et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 1999; 42: 10106.